期刊文献+

恶性胸腔积液临床病理分析 被引量:7

Clinical pathological analysis of malignant pleural effusion
下载PDF
导出
摘要 目的:探讨恶性胸腔积液肿瘤的病理类型、所占比例、临床病理特征及鉴别诊断。方法:利用细胞团块收集器收集体液中脱落细胞,进行病理切片观察细胞形态及免疫组化对108例恶性胸腔积液进行病理诊断及肿瘤病理分型。结果:在119例恶性胸腔积液中,肺腺癌64例,鳞癌6例,小细胞癌10例,恶性间皮瘤15例,胃癌3例,胰腺癌3例,胆囊癌3例,肠癌3例,卵巢癌3例,乳腺癌6例,非何杰金氏淋巴3例。男性61例,女性58例,年龄19-87岁,平均年龄67.8岁。临床主要症状是胸闷、气短、咳嗽、胸痛,伴有原发器官肿瘤病史等。CT表现为胸膜增厚、胸水、多发或单发胸膜结节和原发器官占位性病变。结论:恶性胸腔积液中以肺腺癌多见,其次为恶性间皮瘤,利用细胞团块收集器收集体液中脱落细胞,进行病理切片细胞形态观察及免疫组化,有助于提高癌细胞检出率及肿瘤病理分型,鉴别诊断。 Objective: To investigate the pathological types, the proportion, the clinical pathologic characteristics and the differentialdiagnosis in malignant pleural effusion. Methods :Using the cell mass collector to collect the shedding cells in body fluid, and to observe thepathological changes of 119 cases of malignant pleural effusion by pathological section and immunohistochemistry. Results:In 119 patientswith malignant pleural effusion, pulmonary adenocarcinoma 64 cases, 6 cases of Squamous cell carcinoma, 10 cases of small cell carcinoma15 cases of malignant mesothelioma, 3 cases of gastric cancer, 3 cases of pancreatic carcinoma, 3 cases of gallbladder cancer, 3 cases ofcolorectal cancer, 3 cases of ovarian cancer and 6 cases of breast cancer s, 3 cases of Non-Hodgkin's lymphoma. Male 61 cases, female 58 cases, aged 19 to 87 years old, with an average age of 67.8 years. The main clinical symptoms was chest tightness, shortness of breath, cough,chest pain, with primary tumor organ disease. CT showed pleural thickening, pleural effusion, multiple or solitary pleural nodules and primaryorgan space occupying lesions. Conclusion:Lung adenocarcinoma was common, and the second was malignant mesothelioma in Malignantpleural effusion. Using cell clumps to collector fluid cytology and pathological section to observe cell morphology and immunohistochemical,to improve the detection rate and tumor histological type of cancer cells, differential diagnosis
出处 《甘肃医药》 2016年第5期332-335,共4页 Gansu Medical Journal
基金 甘肃省卫生行业科研计划项目(项目编号:GSWSKY-2015-69)
关键词 细胞团块收集器 恶性胸腔积液 肺癌 免疫组化 cell mass collection malignant pleural effusion lung cancer immunohistochemistry
  • 相关文献

参考文献11

  • 1曹月华, 杨 敏, 陈隆文, 等. 细胞病理学诊断图谱及实验病理技术[M]. 北京: 北京科学技术出版社, 2009:401-3.
  • 2Langman G, Rathinmn S, Papadaki L. Primary localised pleural neurofi- broma: expanding the spectrum of spindle cell tumours of the pleura[J]. J Clin Pathol, 2010, 63(2): 116-118.
  • 3Murugan P, Siddaraju N, Habeebullah S, et al. Review Immunohisto- chemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel- based approach with a brief re- view of the literature [J]. Indian J Pathol Microbiol, 2009, 52(2): 175-181.
  • 4韩军平,王丽曾,罗文潇,马文霞,达春和.细胞团块收集器联合免疫标记在良、恶性胸水中的应用研究[J].中国现代医学杂志,2015,25(35):62-65. 被引量:3
  • 5Delourme J, Dhalluin X, Cortot AB. Malignant pleural mesothelioma: di- agnosis and treatment[J]. Rev Pneumol Clin, 2013, 69(1):26-35.
  • 6张艳梅,付红,张颖.免疫组化在胸膜上皮性恶性肿瘤鉴别诊断中的价值[J].中国肺癌杂志,2007,10(4):320-323. 被引量:8
  • 7Johnson H, Cohen C, Fatima N, et al. Thyroid transcription factor- 1 and napsin a double stain: utilizing different vendorantibodies for diag- nosing lung adenocarcinoma[J]. ActaCytol, 2012,56(6): 596-602.
  • 8Agackiran Y, Ozcan A, Akyurek N, et al. Desmoglein-3 and napsin-A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinomafrom other sub- types [J]. Appl Immunohistochem Mol Morphol,2012,20(4): 350-355.
  • 9Turner Bin, Cacle Pt, Sainz Ira, et al. Napsin-A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of prima- ry pulmonary carcinoma: evaluation of 1674 cases by tissuemicroarray [J]. Arch Pathol lab Med, 2012,136(2): 163-171.
  • 10周秋媛,张惠箴,蒋智铭,汪佩鑫,唐娟.胸腹水沉渣包埋切片中Napsin-A、CK7、TTF-1等的表达及临床意义[J].临床与实验病理学杂志,2013,29(6):671-673. 被引量:17

二级参考文献28

  • 1郭峰,卢兆桐,邹志强.原发性肺腺癌肿瘤标记物Napsin A的研究现状[J].国外医学(肿瘤学分册),2005,32(5):388-391. 被引量:4
  • 2[3]Bateman AC,al-Talib RK,Newman T,et al.Immunohistochemical phenotype of malignant mesothelioma:predictive value of CA125and HBME-1 expression.Histopathology,1997,30(1):49-56.
  • 3[7]Ordonez NG.The immunohistochemical diagnosis of epithelial mesothelioma.Hum Pathol,1999,30(3):313-323.
  • 4[8]Khoor A,Whitsett JA,Stahlman MT,et al.Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma.Hum Pathol,1999,30(6):695-700.
  • 5Tatnell P J, Powell D J, Hill J, et al. Napsins: new human aspartie proteinases. Distinction between two closely related genes[J]. FEBS Lett, 1998,441(1):43-8.
  • 6Cronshaw R F, SchauerVukasinovic V, Powell D J, et al. Inhibition of human napsin A[J]. Protein Pept Lett, 2003,10(1):35-42.
  • 7Johnson H, Cohen C, Fatima N, et al. Thyroid transcription factor 1 and napsin a double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma[J]. Acta Cytol, 2012,56(6):5.
  • 8Agackiran Y, Ozcan A, Akyurek N, et al. Desmoglein3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other s.
  • 9Turner B M, Cagle P T, Sainz I M, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosi.
  • 10Warth A, Muley T, Herpel E, et al. Largescale comparative analyses of immunomarkers for diagnostic subtyping of nonsmallcell lung cancer biopsies[J]. Histopathology, 2012,61(6):1017-25.

共引文献25

同被引文献78

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部